Form 8-K - Current report:
SEC Accession No. 0001558370-20-001042
Filing Date
2020-02-20
Accepted
2020-02-20 07:05:51
Documents
3
Period of Report
2020-02-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 39765
2 EX-99.1 ex-99d1.htm EX-99.1 19359
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 5904
  Complete submission text file 0001558370-20-001042.txt   68464
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 20632524
SIC: 2834 Pharmaceutical Preparations